Cameron Pettinato brings industry, research, and consulting experience spanning oncology, neuroscience, vaccines, and HIV prevention and treatment. Before joining Blue Matter in 2025, he advised biopharma clients at Avalere Health. His prior experience includes a Medical Affairs role at Pfizer and academic research in the life sciences.

Cameron holds an MPH from Boston University with concentrations in Epidemiology and Biostatistics as well as Health Policy and Law, and a BS in Public Health from Temple University.